On April 6, 2021 SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, reported that management will be participating in multiple investor conferences in April 2021 (Press release, SQZ Biotech, APR 6, 2021, View Source [SID1234577633]). Armon Sharei, PhD, chief executive officer, will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference taking place April 12-15, 2021 and will participate in a cell therapy focused panel at the Canaccord Horizons in Oncology Virtual Conference on April 15, 2021. The company will also be hosting one on one meetings at both conferences.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Needham Virtual Healthcare Conference
Presentation: Tuesday, April 13, 2021, 3:45pm EDT
Canaccord Horizons in Oncology Virtual Conference
Panel: Thursday, April 15, 2021, 1:00pm EDT
More information and the webcast for the presentation at Needham will be available on the Investors & Media section of the SQZ website. The webcast will be available for 90 days following the presentation.